国产日韩欧美不卡高清小视频,激情亚洲内射一区二区三区,日日摸夜夜添夜夜添国产95,欧美在线观看一区二区三区免费,亚洲乱码av一区二区三区女同,亚洲女久久久噜噜噜综合,亚洲av日韩av高清在线观看,中文字幕一区二区va在线

血管緊張素原(AGT)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法)

ELISA Kit for Angiotensinogen (AGT)

ANHU; SERPINA8; Angiotensin; Renin Substrate; Serpin Peptidase Inhibitor,Clade A,Member 8(Alpha-1 Antiproteinase,Antitrypsin)

  • 血管緊張素原(AGT)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) 產(chǎn)品包裝(模擬)
  • 血管緊張素原(AGT)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) 產(chǎn)品包裝(模擬)
  • 血管緊張素原(AGT)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) 實(shí)驗(yàn)結(jié)果圖
  • SEA797Ra.jpg 標(biāo)準(zhǔn)曲線圖
  • Certificate 通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證

特異性

本試劑盒用于檢測血管緊張素原(AGT),經(jīng)檢測與其它相似物質(zhì)無明顯交叉反應(yīng)。
由于受到技術(shù)及樣本來源的限制,不可能完成對所有相關(guān)或相似物質(zhì)交叉反應(yīng)檢測,因此本試劑盒有可能與未經(jīng)檢測的其它物質(zhì)有交叉反應(yīng)。

回收率

分別于定值血清及血漿樣本中加入一定量的血管緊張素原(AGT)(加標(biāo)樣品),重復(fù)測定并計(jì)算其均值,回收率為測定值與理論值的比率。

樣本 回收率范圍(%) 平均回收率(%)
serum(n=5) 91-103 96
EDTA plasma(n=5) 81-91 85
heparin plasma(n=5) 92-103 101

精密度

精密度用樣品測定值的變異系數(shù)CV表示。CV(%) = SD/mean×100
批內(nèi)差:取同批次試劑盒對低、中、高值定值樣本進(jìn)行定量檢測,每份樣本連續(xù)測定20 次,分別計(jì)算不同濃度樣本的平均值及SD值。
批間差:選取3個(gè)不同批次的試劑盒分別對低、中、高值定值樣本進(jìn)行定量測定,每個(gè)樣本使用同一試劑盒重復(fù)測定8次,分別計(jì)算不同濃度樣本的平均值及SD值。
批內(nèi)差: CV<10%
批間差: CV<12%

線性

在定值血清及血漿樣本內(nèi)加入適量的血管緊張素原(AGT),并倍比稀釋成1:2,1:4,1:8,1:16的待測樣本,線性范圍即為稀釋后樣本中血管緊張素原(AGT)含量的測定值與理論值的比率。

樣本 1:2 1:4 1:8 1:16
serum(n=5) 90-98% 89-101% 84-93% 80-98%
EDTA plasma(n=5) 88-97% 80-91% 80-90% 85-101%
heparin plasma(n=5) 82-90% 85-93% 87-99% 95-103%

穩(wěn)定性

經(jīng)測定,試劑盒在有效期內(nèi)按推薦溫度保存,其活性降低率小于5%。
為減小外部因素對試劑盒破壞前后檢測值的影響,實(shí)驗(yàn)室的環(huán)境條件需盡量保持一致,尤其是實(shí)驗(yàn)室內(nèi)溫度、濕度及溫育條件。其次由同一實(shí)驗(yàn)員來進(jìn)行操作可減少人為誤差。

實(shí)驗(yàn)流程

1. 實(shí)驗(yàn)前標(biāo)準(zhǔn)品、試劑及樣本的準(zhǔn)備;
2. 加樣(標(biāo)準(zhǔn)品及樣本)100µL,37°C孵育1小時(shí);
3. 吸棄,加檢測溶液A100µL,37°C孵育1小時(shí);
4. 洗板3次;
5. 加檢測溶液B100µL,37°C孵育30分鐘;
6. 洗板5次;
7. 加TMB底物90µL,37°C孵育10-20分鐘;
8. 加終止液50µL,立即450nm讀數(shù)。

實(shí)驗(yàn)原理

將血管緊張素原(AGT)抗體包被于96孔微孔板中,制成固相載體,向微孔中分別加入標(biāo)準(zhǔn)品或標(biāo)本,其中的血管緊張素原(AGT)與連接于固相載體上的抗體結(jié)合,然后加入生物素化的血管緊張素原(AGT)抗體,將未結(jié)合的生物素化抗體洗凈后,加入HRP標(biāo)記的親和素,再次徹底洗滌后加入TMB底物顯色。TMB在過氧化物酶的催化下轉(zhuǎn)化成藍(lán)色,并在酸的作用下轉(zhuǎn)化成最終的黃色。顏色的深淺和樣品中的血管緊張素原(AGT)呈正相關(guān)。用酶標(biāo)儀在450nm波長下測定吸光度(O.D.值),計(jì)算樣品濃度。

相關(guān)產(chǎn)品

編號(hào) 適用物種:Rattus norvegicus (Rat,大鼠) 應(yīng)用(僅供研究使用,不用于臨床診斷!)
UAPA797Ra61 血管緊張素原(AGT)活性蛋白 Cell?culture;?Activity?Assays.
URPA797Ra01 血管緊張素原(AGT)重組蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
UEPA797Ra61 血管緊張素原(AGT)真核蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
UPAA797Ra01 血管緊張素原(AGT)多克隆抗體 WB
ULAA797Ra71 血管緊張素原(AGT)多克隆抗體(生物素標(biāo)記) WB; IHC; ICC.
ULAA797Ra81 血管緊張素原(AGT)多克隆抗體(異硫氰酸熒光素標(biāo)記) WB; IHC; ICC; IF.
UMAA797Ra25 血管緊張素原(AGT)單克隆抗體 ICC/IF
UMAA797Ra21 血管緊張素原(AGT)單克隆抗體 WB; IHC
UMAA797Ra22 血管緊張素原(AGT)單克隆抗體 WB
UMAA797Ra23 血管緊張素原(AGT)單克隆抗體 WB
UMAA797Ra24 血管緊張素原(AGT)單克隆抗體 WB; IHC
UMAA797Ra27 血管緊張素原(AGT)單克隆抗體 IHC
UMAA797Ra26 血管緊張素原(AGT)單克隆抗體 WB; ICC/IF
UFAA797Ra02 抗血管緊張素原(AGT)單克隆抗體 FCM
USEA797Ra 血管緊張素原(AGT)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) Enzyme-linked immunosorbent assay for Antigen Detection.
ULMA797Ra 血管緊張素原(AGT)等多因子檢測試劑盒(流式熒光發(fā)光法) FLIA Kit for Antigen Detection.
UKSA797Ra01 血管緊張素原(AGT)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗(yàn)法) Main materials for "Do It (ELISA Kit) Yourself".

參考文獻(xiàn)

雜志 參考文獻(xiàn)
Transplant International Elevated urinary angiotensinogen a marker of intrarenal renin angiotensin system in hypertensive renal transplant recipients: does it play a role in development of proteinuria in hypertensive renal transplant patients? [Wiley: source]
Amyloid The relation between urinary angiotensinogen and proteinuria in renal AA amyloidosis patients [PubMed: 22320202]
Pediatric Mephrology Urinary angiotensinogen as a marker of intrarenal angiotensin II activity in adolescents with primary hypertension [PubMed: PMC3661928]
Acta Paediatrica Urinary angiotensinogen as a novel marker of obstructive nephropathy in children [Pubmed: 23772991]
Journal of the Renin-Angiotensin-Aldosterone System Association between urinary angiotensinogen, hypertension and proteinuria in pregnant women with preeclampsia [Sagepub: Source]
Pediatric Nephrology MP707 CHARACTERISTICS AND OUTCOMES OF CHILDREN WITH AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE COHORT FROM THE ESPN/ERA-EDTA REGISTRY [Oxfordjournals:Source]
journal of human hypertension Relationship between blood pressure var [PubMed: 26223347]
PLoS One Higher Serum Angiotensinogen Is an Indicator of IgA Vasculitis with Nephritis Revealed by Comparative Proteomes Analysis [PubMed: 26098644]
MKA Korelasi pengukuran antropometri dengan tekanan darah dan angiotensinogen plasma pada dewasa [Index.Php: Art]
Journal of Human Hypertension Relationship between blood pressure variability and renal activity of the renin-angiotensin system. [pubmed:26223347]
Acta Pharmacol Sin. Pharmacological evidence: a new therapeutic approach to the treatment of chronic heart failure through SUR2B/Kir6.1 channel in endothelial cells. [pubmed:27890915]
Journal of Chromatography A Application of a new procedure for liquid chromatography/mass spectrometry profiling of plasma amino acid-related metabolites and untargeted shotgun proteomics to identify mechanisms and biomarkers of calcific aortic stenosis [S0021967317311858]
Life?Sciences Pyrrolidine dithiocarbamate inhibits mouse acute kidney injury induced by diclofenac by targeting oxidative damage, cytokines and NF-κB activity [Pubmed:30036488]
American Journal of Physiology-Renal?Physiology Role of (Pro) Renin Receptor in Albumin Overload-Induced Nephropathy in Rats [Pubmed:29846109]
Methods in Molecular Biology Quantitation of Total and Free Thiol Angiotensinogen as a Prognostic Marker for Preeclampsia [Pubmed: 31069778]
J Transl Med Multi-omic signatures of atherogenic dyslipidaemia: pre-clinical target identification and validation in humans [33407555]
Hypertens Res Association of Ang-(1¨C7) and des-Arg 9 BK as new biomarkers of obesity and cardiometabolic risk factors in adolescents [33568792]
Physiol Rep (Pro) renin receptor antagonist PRO20 attenuates nephrectomy?\induced nephropathy in rats via inhibition of intrarenal RAS and Wnt/|??\catenin signaling [34057312]
Cancer Cell Int A novel strategy to identify candidate diagnostic and prognostic biomarkers for gastric cancer [34215253]
留言咨詢
葵青区| 吉隆县| 侯马市| 东台市| 洛扎县| 文成县| 宁陵县| 泽州县| 恭城| 汉阴县| 习水县| 景宁| 井冈山市| 大同县| 龙江县| 永安市| 易门县| 洪湖市| 宁津县| 天峨县| 肥东县| 铁岭市| 黄石市| 和政县| 枣强县| 洱源县| 若尔盖县| 神木县| 宁国市| 大足县| 博白县| 新蔡县| 丰都县| 景德镇市| 襄城县| 江陵县| 班戈县| 敖汉旗| 苏州市| 崇义县| 富宁县|